Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

Related Articles by Review for PubMed (Select 22386508)

1.

Asthma outcomes: exacerbations.

Fuhlbrigge A, Peden D, Apter AJ, Boushey HA, Camargo CA Jr, Gern J, Heymann PW, Martinez FD, Mauger D, Teague WG, Blaisdell C.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S34-48. doi: 10.1016/j.jaci.2011.12.983. Review.

2.

Treatment for acute asthma in the Emergency Department: practical aspects.

Urso DL.

Eur Rev Med Pharmacol Sci. 2010 Mar;14(3):209-14. Review.

PMID:
20391960
3.

Asthma outcomes: symptoms.

Krishnan JA, Lemanske RF Jr, Canino GJ, Elward KS, Kattan M, Matsui EC, Mitchell H, Sutherland ER, Minnicozzi M.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S124-35. doi: 10.1016/j.jaci.2011.12.981. Review.

4.

Asthma outcomes: healthcare utilization and costs.

Akinbami LJ, Sullivan SD, Campbell JD, Grundmeier RW, Hartert TV, Lee TA, Smith RA.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S49-64. doi: 10.1016/j.jaci.2011.12.984. Review.

5.

Asthma outcomes: biomarkers.

Szefler SJ, Wenzel S, Brown R, Erzurum SC, Fahy JV, Hamilton RG, Hunt JF, Kita H, Liu AH, Panettieri RA Jr, Schleimer RP, Minnicozzi M.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S9-23. doi: 10.1016/j.jaci.2011.12.979. Review.

6.

The patient with asthma in the emergency department.

Adams JY, Sutter ME, Albertson TE.

Clin Rev Allergy Immunol. 2012 Aug;43(1-2):14-29. doi: 10.1007/s12016-011-8273-z. Review.

PMID:
21597902
7.

Asthma outcomes: pulmonary physiology.

Tepper RS, Wise RS, Covar R, Irvin CG, Kercsmar CM, Kraft M, Liu MC, O'Connor GT, Peters SP, Sorkness R, Togias A.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S65-87. doi: 10.1016/j.jaci.2011.12.986. Review.

8.

Corticosteroids for preventing relapse following acute exacerbations of asthma.

Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW.

Cochrane Database Syst Rev. 2001;(1):CD000195. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD000195.

PMID:
11279682
9.

Asthma outcomes: composite scores of asthma control.

Cloutier MM, Schatz M, Castro M, Clark N, Kelly HW, Mangione-Smith R, Sheller J, Sorkness C, Stoloff S, Gergen P.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S24-33. doi: 10.1016/j.jaci.2011.12.980. Review.

10.

Corticosteroids for preventing relapse following acute exacerbations of asthma.

Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000195. Review.

PMID:
17636617
11.

Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.

Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005535. Review. Update in: Cochrane Database Syst Rev. 2010;(5):CD005535.

PMID:
16235410
12.

Corticosteroids for preventing relapse following acute exacerbations of asthma.

Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW.

Cochrane Database Syst Rev. 2000;(2):CD000195. Review. Update in: Cochrane Database Syst Rev. 2001;(1):CD000195.

PMID:
10796506
13.

Treatment strategies for reducing asthma-related emergency department visits.

Ornato JP.

J Emerg Med. 2007 Jan;32(1):27-39. Review.

PMID:
17239730
14.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003137. Review. Update in: Cochrane Database Syst Rev. 2011;(5):CD003137.

PMID:
17054161
15.

Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.

Edmonds ML, Milan SJ, Camargo CA Jr, Pollack CV, Rowe BH.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD002308. doi: 10.1002/14651858.CD002308.pub2. Review.

PMID:
23235589
16.

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2011 May 11;(5):CD003137. doi: 10.1002/14651858.CD003137.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003137.

PMID:
21563136
17.

Asthma outcomes: quality of life.

Wilson SR, Rand CS, Cabana MD, Foggs MB, Halterman JS, Olson L, Vollmer WM, Wright RJ, Taggart V.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S88-123. doi: 10.1016/j.jaci.2011.12.988. Review.

18.

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.

Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N.

Pharmacoeconomics. 2012 Nov 1;30(11):991-1004. doi: 10.2165/11597160-000000000-00000. Review.

PMID:
22950547
20.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ram FS, Cates CJ, Ducharme FM.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003137. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003137.

PMID:
15674901
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk